Brenner Tumor of Ovary - 25 Studies Found Status Study Completed Study Name: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer Condition: Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Date: 1999-11-01 Interventions: Drug: paclitaxel Given IV Completed Study Name: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin Condition: Brenner Tumor Fallopian Tube Cancer Drug: belinostat Given IV Completed Study Name: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Condition: Brenner Tumor Fallopian Tube Cancer Biological: sargramostim Given Completed Study Name: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma Condition: Brenner Tumor Fallopian Tube Cancer Drug: paclitaxel Given IV Recruiting Study Name: Metformin Hydrochloride and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition: Brenner Tumor Malignant Ascites Drug: paclitaxel Given IV Completed Study Name: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Condition: Brenner Tumor Fallopian Tube Cancer Drug: carboplatin Given intrap Completed Study Name: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Condition: Brenner Tumor Fallopian Tube Cancer Procedure: adjuvant therapy Drug: paclitax Recruiting Study Name: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condition: Ovarian Brenner Tumor Ovarian Carcinosarcoma Drug: Gemcitabine Hydrochloride Completed Study Name: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Condition: Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor< Date: 2011-02-10 Interventions: Drug: TLR8 Agonist VTX-2337 Gi Suspended Study Name: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Condition: Nausea and Vomiting Ovarian Brenner Tumor Procedure: Adjuvant Therapy An Next >>>